Hydrinity Accelerated Skin Science Expands into Indonesia
The company is proud to announce the new partnership with PT. Regenesis Indonesia NASHVILLE, Tenn., Nov. 12, 2024 /PRNewswire/ — Today, Hydrinity Accelerated Skin Science, the fastest growing professional skincare brand in the US, is proud to announce their new partnership with PT. Regenesis
ACR Poker Offers 15 WSOP Paradise Packages for $50 Million Guaranteed Super Main Event
Turn $95 into a $30,000 package for the largest guaranteed live poker tournament SAN JOSE, Costa Rica, Nov. 12, 2024 /PRNewswire/ — ACR Poker is offering players a chance to be part of history by qualifying for the largest guaranteed live poker tournament ever. This December in the Bahamas,
Avalara and Ledgible Partner to Solve for IRS Form 1099 Digital Asset Cost Basis Reporting
ATLANTA, Nov. 12, 2024 /PRNewswire/ — Ledgible, the leading platform for digital asset tax and accounting, today announced it has partnered with Avalara, Inc., a leading provider of tax compliance automation software for businesses of all sizes, to offer enhanced digital asset cost basis repo
RealTime eClinical Solutions Expands its Professional Services Offerings to Accelerate eClinical Adoption
SAN ANTONIO, Nov. 12, 2024 /PRNewswire/ — RealTime eClinical Solutions, a leader in cloud-based software for the clinical research industry, is proud to announce the expansion of its Professional Services, designed to help clinical research sites, AMCs, sponsors, and CROs fully leverage the ca
Asian World Film Festival Announces Focus on Hong Kong Program to Run November 14-17, 2024
Contemporary Lineup Includes “Twilight of the Warriors: Walled In,” Hong Kong’s Official Oscar® Submission, and Multi-Award-Winner “Mad Fate” Classic Screenings to Feature “Comrades: Almost a Love Story” and “In the Mood for Love“ LOS ANGELES, N
Caliway Announced EMA Orphan Drug Designation Granted to CBL-514 for Dercum’s Disease Treatment
– CBL-514 is the first and only drug to receive EMA Orphan Drug Designation for Dercum’s disease treatment. – CBL-514 received both FDA Orphan Drug Designation and Fast Track designation for Dercum’s disease treatment earlier this year. – CBL-514 Phase 2 study for
CALL FOR ENTRIES – 2025 CANADIAN HILLMAN PRIZES FOR JOURNALISM
* ATTENTION JOURNALISTS, EDITORS AND AWARDS COORDINATORS * DEADLINE: JANUARY 15, 2025 Annual prizes honour excellence in journalism in service of the common good TORONTO, Nov. 12, 2024 /CNW/ – The Sidney Hillman Foundation is now accepting nominations for the 2025 Canadian Hillman Prizes, hon
A Decade of League: 10 Years of Transforming Healthcare at Scale
Healthcare CX platform leader announces 25 million user milestone and industry-leading growth of 158% compound annual growth rate TORONTO, Nov. 12, 2024 /PRNewswire/ – League, the leading healthcare consumer experience (CX) platform serving over 25 million users, is celebrating its 10th anni
Corporate Technologies enters its 17th market with the acquisition of RSPN in Iowa
EDEN PRAIRIE, Minn., Nov. 12, 2024 /PRNewswire/ — Corporate Technologies, a leading national managed service provider (MSP) offering IT and cybersecurity solutions, has acquired RSPN, an MSP serving SMB customers in the Cedar Falls and Waterloo region of Iowa. The acquisition expands Corpor
Digital Finance Research Institute: Charles Brown’s New AI System Offers Intelligent Solutions for Dynamic Market Conditions
CHICAGO, Nov. 12, 2024 /PRNewswire/ — Digital Finance Research Institute has launched its new AI-powered Smart Investment Decision System, marking a pivotal advancement in quantitative trading technology. This system leverages deep learning, big data analytics, and machine learning to analyze
